About XRC Labs
Pre-seed–Series A accelerator investing in consumer-behavior technologies; small 10–15 cohorts, 330+ mentors acting as team extensions, and corporate partners (Mastercard, Estée Lauder, TJX) driving commercial outcomes.

Pre-seed–Series A accelerator investing in consumer-behavior technologies; small 10–15 cohorts, 330+ mentors acting as team extensions, and corporate partners (Mastercard, Estée Lauder, TJX) driving commercial outcomes.
1CC.vc is a digital asset trading platform that provides users with access to a wide range of digital assets, including cryptocurrencies, stablecoins, and tokens. The platform is designed to be user-friendly and features a variety of features, such as charting tools, real-time trading, margin trading, and advanced order types. Additionally, 1CC.vc also features a variety of educational resources to help users learn more about digital assets and trading. The platform is built on top of a secure and reliable infrastructure, and its services are available in both English and Chinese.
Venture studio and fund that co‑incubates with LifePoint executives, giving startups direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus.
30n is a venture capital firm focused on investing in early-stage startups with a mission to create an equitable and sustainable future. They invest in a range of industries, including technology, media, health care, and finance, and are committed to creating long-term value for their portfolio companies. Their portfolio includes companies working on artificial intelligence, health tech, software, hardware, and more. The firm also provides resources to their portfolio companies such as mentorship, network access, and strategic advice. 30n has offices in San Francisco, New York, and London.
Early-stage partner for founders building iconic, industry-transforming companies, demonstrated by two new funds totaling $347M.
Acts as a VC and venture studio—co-founds startups with 25–30% of capital, assembles top‑1% specialists, and builds national‑capability defense, industrials, and bio‑infrastructure companies with corporate partners.
Women-led VC systematically backs clinically rigorous, behaviorally grounded wellbeing startups tackling stigmatized areas—alcohol use disorder, menopause, mental health—using stigma as an investing edge and insisting on consumer-grade UX.